InnoCore's SynBiosys® debuts in first product

Friday 13 September 2013

Print this page

InnoCore's SynBiosys® debuts in first product

InnoCore's multi-block copolymer system SynBiosys® has become available in a commercial clinical product. Since 2003 InnoCore has worked on the development of the SynBiosys biodegradable polymeric platform for controlled release of pharmaceutical active ingredients.

A SynBiosys® coating is applied to control the release of a drug from an innovative dual therapy stent, (the Combo Stent), a cardiovascular stent developed and marketed by OrbusNeich. The Combo Stent recently received a CE Mark allowing the product to be sold in Europe and several markets in the Asia Pacific and Middle East regions.

InnoCore Pharmaceuticals is a drug delivery company, specialized in the development of long acting and minimally invasive drug delivery products for the treatment of chronic diseases. It is located in the MedTech Center on the Healthy Ageing Campus Netherlands in Groningen.

More information: www.innocorepharma.com